RESUMO
INTRODUCTION/AIMS: T2 magnetic resonance imaging (MRI) mapping has been applied to carpal tunnel syndrome (CTS) for quantitative assessment of the median nerve. However, quantitative changes in the median nerve before and after surgery using T2 MRI mapping remain unclear. We aimed to investigate whether pathological changes could be identified by pre- and postoperative T2 MRI mapping of the median nerve in CTS patients after open carpal tunnel release. METHODS: This was a prospective study that measured median nerve T2 and cross-sectional area (CSA) values at the distal carpal tunnel, hamate bone, proximal carpal tunnel, and forearm levels pre- and postoperatively. Associations between T2, CSA, and nerve conduction latency were also evaluated. RESULTS: A total of 36 patients with CTS (mean age, 64.5 ± 11.7 years) who underwent surgery were studied. The mean preoperative T2 values significantly decreased from 56.3 to 46.9 ms at the proximal carpal tunnel levels (p = .001), and from 52.4 to 48.7 ms at the hamate levels postoperatively (p = .04). Although there was a moderate association between preoperative T2 values at the distal carpal tunnel levels and distal motor latency values (r = -.46), other T2 values at all four carpal tunnel levels were not significantly associated with CSA or nerve conduction latency pre- or postoperatively. DISCUSSION: T2 MRI mapping of the carpal tunnel suggested a decrease in nerve edema after surgery. T2 MRI mapping provides quantitative information on the median nerve before and after surgery.
Assuntos
Síndrome do Túnel Carpal , Imageamento por Ressonância Magnética , Nervo Mediano , Condução Nervosa , Humanos , Síndrome do Túnel Carpal/cirurgia , Síndrome do Túnel Carpal/diagnóstico por imagem , Nervo Mediano/diagnóstico por imagem , Feminino , Masculino , Pessoa de Meia-Idade , Idoso , Condução Nervosa/fisiologia , Estudos Prospectivos , AdultoRESUMO
The prognosis for bile duct carcinoma in dogs is generally believed to be poor. However, only a few studies have evaluated the postoperative outcomes in such cases. The objective of this case series was to describe the postoperative outcomes of localized intrahepatic bile duct carcinoma in dogs. The electronic medical records of 16 dogs with bile duct carcinoma were reviewed, and 6 dogs were included in the study. All cases were diagnosed as bile duct carcinoma using postoperative pathology, and five of them had already been diagnosed using preoperative core biopsy. The tumors in all of the dogs were confirmed as completely resected on histopathological examination. Two dogs received toceranib following the surgery. The median follow-up time was 693 days (range, 420-1386 days), with a median survival time of 894 days (range, 420-1386 days). Local recurrence or distant metastases were detected in two of the six dogs (33%) on 354 and 398 days following surgery, respectively. The median progression-free survival was 492 days (range, 354-1386 days). In conclusion, dogs with localized intrahepatic bile duct carcinoma had a good prognosis following complete surgical resection.
Assuntos
Carcinoma , Doenças do Cão , Animais , Ductos Biliares , Carcinoma/veterinária , Doenças do Cão/tratamento farmacológico , Doenças do Cão/cirurgia , Cães , Fígado , PirróisRESUMO
Canine hemangiosarcoma (HSA) has an extremely poor prognosis, making it necessary to develop new systemic treatment methods. MicroRNA-214 (miR-214) is one of many microRNAs (miRNA) that can induce apoptosis in HSA cell lines. Synthetic miR-214 (miR-214/5AE), which showed higher cytotoxicity and greater nuclease resistance than mature miR-214, has been developed for clinical application. In this study, we evaluated the effects of miR-214/5AE on stage 2 HSA in a mouse model. Mice intraperitoneally administered with miR-214/5AE (5AE group) had significantly fewer intraperitoneal dissemination tumor foci (median number: 72.5 vs. 237.5; p < 0.05) and a lower median foci weight (0.26 g vs. 0.61 g; p < 0.05). Mice in the 5AE group had increased expression of p53 and cleaved caspase-3, and a significantly lower proportion of Ki-67-positive cells, than those in the non-specific miR group. Notably, no significant side effects were observed. These results indicate that intraperitoneal administration of miR-214/5AE exhibits antitumor effects in an intraperitoneal dissemination mouse model of HSA by inducing apoptosis and suppressing cell proliferation. These results provide a basis for future studies on the antitumor effect of miR-214/5AE for HSA.
Assuntos
Doenças do Cão , Hemangiossarcoma , MicroRNAs , Doenças dos Roedores , Animais , Apoptose , Linhagem Celular Tumoral , Proliferação de Células , Modelos Animais de Doenças , Cães , Regulação Neoplásica da Expressão Gênica , Hemangiossarcoma/tratamento farmacológico , Hemangiossarcoma/genética , Hemangiossarcoma/veterinária , Camundongos , MicroRNAs/genética , Doenças dos Roedores/genéticaRESUMO
OBJECTIVES: This study aimed to compare the pre- and postoperative morphology of the median nerve using three-dimensional (3-D) MRI in patients with carpal tunnel syndrome (CTS). METHODS: We assessed 31 patients with CTS who underwent open carpal tunnel release and T2*-weighted MRI of the wrist preoperatively and at 6 months postoperatively. The median nerve morphology was evaluated on the basis of the cross-sectional areas (CSAs) and cross-sectional volumes (CSVs). The association between these MRI findings and nerve conduction studies was also evaluated. RESULTS: The mean preoperative CSA and CSV values at the proximal carpal tunnel level significantly decreased from 22.2 mm2 and 24.4 mm3 to 16.5 mm2 and 18.1 mm3, respectively, postoperatively. Median nerve swelling at the proximal carpal tunnel level was observed in 29 (94%) and 23 (74%) patients before and after surgery, respectively. The mean preoperative CSA and CSV values at the hamate level significantly increased from 9.9 to 12.3 mm2 and from 10.9 to 13.5 mm3 after surgery, respectively. Nerve narrowing at the hamate bone level was preoperatively observed in 28 (90%) patients and postoperatively in 21 (68%) patients. Preoperative CSA and CSV values at the proximal carpal tunnel were significantly associated with preoperative distal motor and sensory latency. CONCLUSIONS: Visual confirmation of the median nerve morphology using 3-D MRI is useful when considering postoperative recovery and explaining the nerve condition to the patients. KEY POINTS: ⢠The 3-D morphology of the median nerve after carpal tunnel release can be delineated using 3-D MRI. ⢠Preoperative swelling of the median nerve in the 2-D and 3-D planes reflects the severity of carpal tunnel syndrome. ⢠Visual confirmation of the median nerve morphology is useful when considering median nerve recovery after carpal tunnel release and for explaining the condition of the nerve to patients.
Assuntos
Síndrome do Túnel Carpal , Nervo Mediano , Síndrome do Túnel Carpal/diagnóstico por imagem , Síndrome do Túnel Carpal/cirurgia , Humanos , Imageamento por Ressonância Magnética/métodos , Nervo Mediano/patologia , Punho/diagnóstico por imagem , Articulação do PunhoRESUMO
OBJECTIVE: We examined the surgical outcomes of the Sauvé-Kapandji (S-K) procedure using a headless compression screw and a metal cancellous screw in patients with rheumatoid arthritis (RA). METHODS: This retrospective study included 41 RA patients who underwent the S-K procedure for distal radioulnar joint disorders with two screws: headless compression screws (HCS group, n = 20) and cannulated cancellous screws (CCS group, n = 21). Clinical and radiographic outcomes were assessed 1 year after surgery. Radiographic outcomes included bony union of the distal radioulnar joint (DRUJ), bone resorption around the screw, a screw back-out, and use of additional K-wire. We investigated any complications related to the screw head. RESULTS: All 20 patients in the HCS group showed bone fusion of the DRUJ. In the CCS group, an asymptomatic non-union was observed in one patient and additional K-wire was needed to stabilize the DRUJ in three patients. No patients complained of any complications related to the screw head in the HCS group, while the CCS group demonstrated the hardware protrusion in two patients who complained of tenderness or discomfort at the screw head. CONCLUSIONS: The use of a headless compression screw in the S-K procedure is useful in patients with RA.
Assuntos
Artrite Reumatoide/cirurgia , Artrodese/métodos , Parafusos Ósseos , Articulação do Punho/cirurgia , Adulto , Idoso , Idoso de 80 Anos ou mais , Artrite Reumatoide/diagnóstico por imagem , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Radiografia , Estudos Retrospectivos , Resultado do Tratamento , Articulação do Punho/diagnóstico por imagem , Adulto JovemRESUMO
The phase transition of pharmaceutical excipients that can be induced by humidifying or heating is well-known to increase the hardness of orally disintegrating tablets (ODTs). However, these conditions are not applicable to drug substances that are chemically unstable against such stressors. Here, we describe a system which enhances the hardness of tablets containing water-insoluble polymers by using high-pressure carbon dioxide (CO2). On screening of 26 polymeric excipients, aminoalkyl methacrylate copolymer E (AMCE) markedly increased tablet hardness (+155N) when maintained in a high-pressure CO2 environment. ODTs containing 10% AMCE were prepared and treatment with 4.0MPa CO2 gas at 25°C for 10min increased the hardness to +30N, whose level corresponded to heating at 70°C for 720min. In addition, we confirmed the effects of CO2 pressure, temperature, treatment time, and AMCE content on the physical properties of ODTs. Optimal pressure of CO2 gas was considered to be approximately 3.5MPa for an AMCE formula, as excessive pressure delayed the disintegration of ODTs. Combination of high-pressure CO2 gas and AMCE is a prospective approach for increasing the tablet hardness for ODTs, and can be conducted without additional heat or moisture stress using a simple apparatus.
Assuntos
Dióxido de Carbono/química , Química Farmacêutica/métodos , Polímeros/química , Polímeros/metabolismo , Água/química , Água/metabolismo , Administração Oral , Solubilidade , ComprimidosRESUMO
Oral oil formulations have been reported to deliver drugs into the lymph. Lymphatic delivery of immunomodulatory drugs can more efficiently expose the drugs to T-cells in lymph, consequently induce higher efficacy and lower side effects. In this study, effects of tacrolimus oral oil formulations on drug blood exposure, and on inhibition of T-cell's interleukin-2 (IL-2) production were investigated in rats. Oil formulations (sunflower oil, cacao butter, medium chain triglyceride, and palm oil) dissolving tacrolimus showed lower drug blood concentration than a solid dispersion formulation (SDF). The sunflower oil, and cacao butter formulations suppressed drug blood exposure to 50% of the SDF, and inhibited T-cell's IL-2 production similar to the SDF. In vitro digestion tests indicated that slower digestion of the oils might reduce amount and rate of tacrolimus blood absorption. The cacao butter formulations showed 3.0 times more rapid tacrolimus absorption to lymphatic fluid than the SDF. Ratio of the rate constants of absorption into lymph to that into blood was higher in oil formulations (15 times in cacao butter, 15 times sunflower oil, and 3.5 times palm oil) than in the SDF. These results indicated that the oral oil formulations might be suitable for reduced tacrolimus blood concentration for low systemic side effects, and keep high lymph concentration for high efficacy in organ transplantation patients.
Assuntos
Sistemas de Liberação de Medicamentos/métodos , Interleucina-2/antagonistas & inibidores , Linfonodos/efeitos dos fármacos , Óleos de Plantas/administração & dosagem , Linfócitos T/efeitos dos fármacos , Tacrolimo/administração & dosagem , Animais , Química Farmacêutica , Gorduras na Dieta/administração & dosagem , Gorduras na Dieta/farmacocinética , Relação Dose-Resposta a Droga , Interleucina-2/biossíntese , Linfonodos/metabolismo , Masculino , Óleo de Palmeira , Óleos de Plantas/química , Óleos de Plantas/farmacocinética , Ratos , Ratos Endogâmicos Lew , Óleo de Girassol , Linfócitos T/metabolismo , Tacrolimo/química , Tacrolimo/farmacocinéticaRESUMO
PURPOSE: Sepantronium bromide (YM155) is administered by 168-hour continuous infusions in clinical studies due to its time-dependent pharmacological efficacy and rapid elimination from plasma. To enable more convenient administration, i.e., bolus injections with low frequency, we prepared liposomal formulations of YM155 and evaluated their antitumor activities. METHODS: A kinetic simulation model of liposomal YM155 to predict the free drug concentration in both tumor and plasma was developed. A liposomal formulation with the target drug release rate was prepared based on the simulation. Antitumor activities of the formulation were examined in various tumor xenograft mouse models. In addition, antitumor activities of liposomal formulations with different drug release rates were compared in order to confirm the validity of the simulation-based prediction. RESULTS: Liposomal YM155 with the release half-life of 48 h was prepared as a promising formulation. This formulation showed significantly potent antitumor activities in tumor xenograft models by weekly bolus injections. Further studies demonstrated that this release rate was optimal for YM155 in terms of both efficacy and safety. CONCLUSIONS: We successfully developed a liposomal formulation of YM155 that could substitute for long-term continuous infusion of the drug solution in clinical settings by being given as weekly bolus injections.
Assuntos
Antineoplásicos/farmacocinética , Portadores de Fármacos/química , Imidazóis/farmacocinética , Proteínas Inibidoras de Apoptose/antagonistas & inibidores , Modelos Biológicos , Naftoquinonas/farmacocinética , Animais , Antineoplásicos/administração & dosagem , Antineoplásicos/química , Antineoplásicos/farmacologia , Técnicas de Cultura de Células , Linhagem Celular Tumoral , Química Farmacêutica , Simulação por Computador , Preparações de Ação Retardada , Esquema de Medicação , Desenho de Fármacos , Liberação Controlada de Fármacos , Humanos , Imidazóis/administração & dosagem , Imidazóis/química , Imidazóis/farmacologia , Lipossomos , Masculino , Camundongos Endogâmicos BALB C , Camundongos Nus , Naftoquinonas/administração & dosagem , Naftoquinonas/química , Naftoquinonas/farmacologia , Survivina , Distribuição Tecidual , Ensaios Antitumorais Modelo de XenoenxertoRESUMO
We report a case of primary lung cancer with ossification. A 69-year-old woman was referred to our hospital due to an abnormal shadow on a chest roentgenogram. Chest computed tomography demonstrated an irregular mass with scattered high-density areas in the left lower lung. Excisional biopsy of the mass revealed lung adenocarcinoma, and we performed left lower lobectomy. Histologic examination revealed the tumor to be a papillary adenocarcinoma with ossification. We confirmed that bone morphogenetic protein(BMP)-2 developed from the tumor by a western blot analysis.
Assuntos
Adenocarcinoma/metabolismo , Proteína Morfogenética Óssea 2/metabolismo , Neoplasias Pulmonares/metabolismo , Ossificação Heterotópica/metabolismo , Adenocarcinoma/complicações , Adenocarcinoma/diagnóstico por imagem , Adenocarcinoma de Pulmão , Idoso , Feminino , Humanos , Neoplasias Pulmonares/complicações , Neoplasias Pulmonares/diagnóstico por imagem , Estadiamento de Neoplasias , Ossificação Heterotópica/etiologia , Tomografia Computadorizada por Raios XRESUMO
A 69-year-old woman was referred to our hospital due to an abnormal shadow on a chest roentgenogram. Computed tomographic scanning revealed a complete atelectasis of the left lower lobe. Though the definitive diagnosis was not obtained preoperatively, we performed a left lower lobe excision because atelectasis existed for more than one year. Immunohistochemical staining showed that tumor cells were positive for vimentin, CD34, bcl-2, CD99, and negative for S-100, α-smooth muscle actin. The tumor was diagnosed as a solitary fibrous tumor of the bronchus, which has been rarely reported to date.
Assuntos
Neoplasias Brônquicas/cirurgia , Tumores Fibrosos Solitários/cirurgia , Idoso , Neoplasias Brônquicas/patologia , Feminino , Humanos , Tomografia Computadorizada por Raios X , Resultado do TratamentoRESUMO
A 35-year-old man was referred to our hospital, because of recurrent pneumonia. His chest X-ray film and computed tomography showed mass-like consolidation with a cavity in the right upper lobe. He underwent a bronchoscopic examination, but no diagnosis was established. Therefore a surgical biopsy was performed, but the pathological findings revealed that it was only an inflammatory change without any malignant component. For a while, antibiotic and the steroid treatment was continued resulting in the aggravation of clinical findings. Finally, an upper lobe excision was performed for the complete excision of the lesion. As a result of pathology, pulmonary actinomycosis was diagnosed.
Assuntos
Actinomicose/diagnóstico , Pneumopatias/diagnóstico , Actinomicose/cirurgia , Adulto , Biópsia , Humanos , Pneumopatias/cirurgia , Masculino , Pneumonectomia , Tomografia Computadorizada por Raios XRESUMO
Sepantronium bromide (YM155) exhibits time-dependent antitumor activity, although the plasma half-life of YM155 after a bolus intravenous (i.v.) administration is very short. Therefore, greater antitumor efficacy is obtained by continuous infusion than by bolus i.v. administration. In the present study, we attempted to liposomalize YM155 to obtain a longer circulation time than that achieved by bolus i.v. administration and yet retain sufficient antitumor activity. Encapsulation of YM155 in polyethylene glycol-coated liposomes extended the half-life of the drug, and high tumor accumulation of the drug was observed. Bolus i.v. administration of liposomal YM155 by a weekly administration regimen showed antitumor activity comparable to that obtained by the continuous infusion without severe toxicity in a murine xenograft model. Therefore, this liposomal formulation can be a new dosage form of YM155 that achieves sufficient efficacy and safety and is a more convenient administration regimen for users. It should be noted that liposomal YM155 showed unexpectedly high accumulation in the kidneys. This is a specific finding for liposomal YM155, offering important information for the consideration of the potential toxicity of liposomal YM155.
Assuntos
Antineoplásicos/uso terapêutico , Imidazóis/química , Proteínas Inibidoras de Apoptose/antagonistas & inibidores , Proteínas Inibidoras de Apoptose/química , Naftoquinonas/química , Proteínas Repressoras/antagonistas & inibidores , Proteínas Repressoras/química , Animais , Área Sob a Curva , Linhagem Celular Tumoral , Espectroscopia de Ressonância de Spin Eletrônica , Humanos , Imidazóis/farmacocinética , Rim/efeitos dos fármacos , Lipossomos/química , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Naftoquinonas/farmacocinética , Polietilenoglicóis/química , Neoplasias da Próstata/tratamento farmacológico , Survivina , Distribuição Tecidual , Ensaios Antitumorais Modelo de XenoenxertoRESUMO
A 68-year-old male patient underwent extended thymectomy via median sternotomy, 4 years ago. The pathological diagnosis was thymic atypical carcinoid having invaded the pleura and vessel. During follow-up, the new nodular shadows in the anterior mediastinum were pointed out by a chest computed tomography (CT) scan, 40×38 mm and 11×10 mm in size. We performed again tumor resection and resection of pleural disseminations. The patient was free of clinically evident recurrence 3 years after treatment.
Assuntos
Tumor Carcinoide/mortalidade , Tumor Carcinoide/cirurgia , Neoplasias do Timo/mortalidade , Neoplasias do Timo/cirurgia , Idoso , Humanos , Masculino , Recidiva Local de Neoplasia , Prognóstico , Reoperação , TimectomiaRESUMO
The salting-out taste-masking system is a multiparticulate system consisting of a drug core, a salting-out layer containing salts and water-soluble polymers, and a water-penetration control layer containing water-insoluble materials. The system generates a long lag time (time when released drug is less than 1%) for numbness masking, and a subsequent immediate drug release for high bioavailability. Aiming to contain the system and drugs that cause numbness in oral disintegrating tablets, the system was optimized to reduce the particle size and contain drugs with high water solubility in this study. The amount of coating on the layers, the coating solvent, and the positioning of the components were also optimized. The findings in this study will lead to the provision of numbness-masked oral disintegrating tablets to patients.
Assuntos
Sistemas de Liberação de Medicamentos , Microesferas , Preparações Farmacêuticas/química , Paladar , Acetaminofen/química , Carbonatos/química , Química Farmacêutica , Derivados da Hipromelose , Imipramina/química , Metilcelulose/análogos & derivados , Tamanho da Partícula , Povidona/química , Solubilidade , Espectrofotometria Ultravioleta , ComprimidosRESUMO
In order to improve the pharmacological efficacy of recombinant human interleukin-11 (rhIL11) and to reduce the frequency of administration, we examined the feasibility of chemical modification of rhIL11 by polyethylene glycol. The rhIL11 was chemically modified by using branched type (PEG2), or linear type (PEG) polyethylene glycol-N-hydroxysuccinimide with various molecular weights. Plasma profiles of immunoreactive rhIL11 after i.v. injection of the 20 kDa PEG2 conjugated rhIL11 (PEG2 (20 K)-rhIL11) were determined by ELISA. Peripheral platelet counts after the administration of the various conjugates were measured. Pharmacokinetic analysis revealed that the mean residence time of PEG2 (20 K)-rhIL11 after i.v. injection extensively increased by a factor of ca 60 compared with the native rhIL11. Maximum peripheral platelet increase of 67% for PEG2 (20 K)-rhIL11 and that of 50% for PEG (20 K)-rhIL11 over the control was observed whereas no significant change was associated with the bolus i.v. injection of native rhIL11. On the other hand, the remaining biological activity of these PEGylated-rhIL11s was 14-16% of native rhIL11, suggesting that retention of rhIL11 in plasma is much effective in order to potentiate the pharmacological efficacy of the cytokine. Chemical modification of rhIL11 by PEG is a promising approach for improving the clinical efficacy of rhIL11 by prolonged retention in plasma.
Assuntos
Antineoplásicos , Portadores de Fármacos/química , Interleucina-11 , Polietilenoglicóis/química , Proteínas Recombinantes , Animais , Antineoplásicos/efeitos adversos , Antineoplásicos/sangue , Antineoplásicos/química , Antineoplásicos/farmacologia , Plaquetas/citologia , Plaquetas/efeitos dos fármacos , Linhagem Celular Tumoral , Relação Dose-Resposta a Droga , Ensaio de Imunoadsorção Enzimática , Humanos , Injeções Intravenosas , Interleucina-11/efeitos adversos , Interleucina-11/sangue , Interleucina-11/química , Interleucina-11/farmacologia , Masculino , Taxa de Depuração Metabólica , Camundongos , Camundongos Endogâmicos , Peso Molecular , Contagem de Plaquetas , Proteínas Recombinantes/efeitos adversos , Proteínas Recombinantes/sangue , Proteínas Recombinantes/química , Proteínas Recombinantes/farmacologiaRESUMO
OBJECTIVES: Maf is a family of transcription factor proteins characterized by a typical bZip structure, and mafA, a member of the large-maf family, is a strong transactivator of insulin in cell lines. The present study investigated the expression profiles of the large-maf family proteins in porcine pancreatic tissue and in primary culture cells. METHODS: Immunohistochemical staining was performed to localize each maf protein. Messenger RNA expression was quantitated by real-time polymerase chain reaction, and protein expression was assessed by Western blotting. RESULTS: Islet formation was not as clear in newborn pancreatic tissue as in adult pancreatic tissue. MafA- and c-maf-positive cells were more diffusely localized in pancreatic tissue with fewer mafB-positive cell clusters scattered throughout. By contrast, islet formation was clearer, and positive staining for mafA and c-maf tended to be more prominent in the islets of adult pancreatic tissue. Messenger RNA and protein expressions were consistent with the immunohistochemical findings. MafA, mafB, and c-maf coexpressed with insulin-positive cells, and c-maf coexpressed with glucagon-positive cells in adult porcine pancreas based on the results of a double-staining study. CONCLUSIONS: Large mafs were identified in normal porcine and human pancreas, and the expression levels and localizations of the large mafs in newborn and adult pancreatic tissues differed. Mafs may play important roles in establishing endocrine function during pancreatic cell differentiation.
Assuntos
Linhagem da Célula , Fatores de Transcrição Maf Maior/fisiologia , Pâncreas/química , Animais , Western Blotting , Feminino , Feto/química , Imunofluorescência , Glucagon/análise , Humanos , Imuno-Histoquímica , Insulina/análise , Fatores de Transcrição Maf Maior/análise , Fatores de Transcrição Maf Maior/genética , Fator de Transcrição MafB/análise , Masculino , Pâncreas/embriologia , Pâncreas/fisiologia , Antígeno Nuclear de Célula em Proliferação/análise , Proteínas Proto-Oncogênicas c-maf/análise , RNA Mensageiro/análise , SuínosAssuntos
Bloqueadores do Receptor Tipo 1 de Angiotensina II/uso terapêutico , Antígenos/biossíntese , Glicoproteínas/biossíntese , Hepatite C Crônica/tratamento farmacológico , Mucinas/biossíntese , Fator de Crescimento Transformador beta/biossíntese , Bloqueadores do Receptor Tipo 1 de Angiotensina II/farmacologia , Antígenos de Neoplasias , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Mucina-1RESUMO
BACKGROUND: We studied the effects of a proton pump inhibitor (PPI) and an H2-receptor antagonist (H2-blocker) on angiogenesis during gastric ulcer healing, by examining stromal cell-derived factor (SDF-1) and CXC chemokine receptor 4 (CXCR4) expression in the gastric mucosa. METHODS: Patients with gastric ulcers were allocated to an untreated control group, consisting of patients with active ulcers (GA), healing ulcers (GH), and ulcer scars (GS) or a PPI group (P; given rabeprazole at 20 mg/day), or an H2-blocker group (H; given nizatidine at 800 mg/day). Frozen sections of biopsy specimens were examined by reverse transcription-polymerase chain reaction (RT-PCR) to analyze SDF-1 and CXCR4 mRNA. RESULTS: CXCR4 mRNA levels were elevated in the control (GH and GS patients) group and the H2-blocker group. CXCR4 was significantly elevated in the P-GA subgroup of the PPI group (P<0.01), but its level decreased with time. CONCLUSIONS: In the PPI group, CXCR4 levels were increased in the early phase of ulcer healing and returned to a level similar to that in the control group during the scar phase. These results suggest that PPIs increase the expression of CXCR4 mRNA and thus promote vessel regeneration and maturation, facilitating ulcer healing.